Estimating rare disease prevalence and costs in the USA: a cohort study approach using the Healthcare Cost Institute claims data

Objective The study capitalised on national insurance claims data to gather information on patient characteristics and associated costs to better understand the diagnosis and treatment of rare diseases (RDs).Materials and methods Data from the Healthcare Cost Institute (HCCI) data enclave were analy...

Full description

Saved in:
Bibliographic Details
Main Authors: Keith A Crandall, Christine M Cutillo, Ainslie Tisdale, Mahdi Baghbanzadeh, Reva L Stidd, Manpreet S Khural, Laurie J Hartman, Jeff Greenberg, Kevin B Zhang, Ali Rahnavard
Format: Article
Language:English
Published: BMJ Publishing Group 2024-04-01
Series:BMJ Public Health
Online Access:https://bmjpublichealth.bmj.com/content/2/1/e000346.full
Tags: Add Tag
No Tags, Be the first to tag this record!